Amgen is delighted to announce the launch of the Competitive Grant Program in Migraine Research, which will provide an opportunity for early career investigators in the United States to compete for individual grants of US$50,000–150,000 for novel research proposals that seek to advance the medical knowledge of migraine.
The program is limited to proposals from early career investigators (interns, residents, headache medicine fellows, and healthcare professionals within 5 years of completion of training) based in the United States and requires a letter of recommendation from their department or laboratory head.
The deadline for applications is Friday, September 3, 2021 (11:59 PT).
Once selected, Amgen will contract with grant awardees per Amgen standard contract requirements. Open the following link for details on Amgen’s standard contract requirements.
